Latest News

Date Title Topic
17 Feb 2014 R-GCVP as First Line Treatment for DLBCL Patients with Cardiac Comorbidity Haematologic malignancies
17 Feb 2014 How to Reset Strategies to Maximise the Potential of PI3K/AKT/mTOR Inhibitors in Cancer Therapy Anticancer agents & Biologic therapy
14 Feb 2014 ESMO Interview: Franco Cavalli Comments on the Release of the World Cancer Report 2014 Bioethics, legal and economic issues
13 Feb 2014 FDA Approves Ibrutinib for Chronic Lymphocytic Leukaemia Haematologic malignancies - Anticancer agents & Biologic therapy
12 Feb 2014 Who are the Originators of Innovative Medicines in the EU? Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
11 Feb 2014 Rare Cancers: The Challenge of Accurate Diagnosis
06 Feb 2014 World Cancer Report 2014 Cancer prevention
06 Feb 2014 ECC 2013 Webcasts
05 Feb 2014 SWITCH Study of Efficacy and Safety of Sorafenib/Sunitinib vs. Sunitinib/Sorafenib in the Treatment of mRCC Genitourinary cancers - Anticancer agents & Biologic therapy
04 Feb 2014 Enzalutamide in Chemotherapy-Naive mCRPC Genitourinary cancers - Anticancer agents & Biologic therapy
04 Feb 2014 ESMO Supports World Cancer Day 2014 Bioethics, legal and economic issues
03 Feb 2014 Analysis of Somatic Point Mutations in Exome Sequences Translational research
Liver Cancer
31 Jan 2014 Overcoming Platinum Resistance in Ovarian Cancer – The PRECEDENT Trial Gynaecologic malignancies